Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set
Scope-PRO
Scope-PRO: Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set
1 other identifier
observational
900
1 country
1
Brief Summary
The systematic recording of patient-reported symptoms and health-related quality of life (patient-reported outcomes, PROs) is a central component of oncological care. Currently, however, screening for support needs in German hospitals is inconsistent and uses different assessment tools, leading to heterogeneity, redundant surveys, and limited comparability of results. This complicates standardized, patient-centered, and cross-sector care, as well as the early identification of therapy-associated side effects and support needs. The aim of the study is to investigate the acceptance and relevance of the core set of questions from the perspective of both cancer patients and professional healthcare providers. Cancer patient acceptance will be measured by the proportion of fully completed questionnaires, while cancer patient relevance will be assessed using a feedback form. The professional perspective will be gathered through guided feedback in quality circles conducted regularly in accordance with internal standards
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2025
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
April 1, 2026
March 1, 2026
1.1 years
November 18, 2025
March 29, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Proportion of Participants with Complete Core Question Set Completion at Baseline
Description Acceptance is operationalised as the proportion of enrolled cancer patients who fully complete the predefined Scope-PRO core question set at baseline. Questionnaire completeness is used as an indirect indicator of acceptability. Unit of Measure Proportion (%)
Baseline
Participant-Reported Acceptance Score (Study-Specific Acceptance Feedback Questionnaire) at Baseline
Participant-reported acceptance is assessed using a study-specific feedback questionnaire evaluating comprehensibility, perceived burden, and overall acceptability of the core question set. Scale Study-specific Acceptance Feedback Questionnaire Range: 1 to 4 Higher scores indicate higher acceptance.
Baseline
Secondary Outcomes (8)
Participant-Reported Relevance Score of the Core Question Set
Baseline
Centre-Level Characteristics and Implementation Practices of PROM-Based Supportive Care Screening
Baseline and last-patient-in at the respective institution
Severity of Prespecified Symptoms (Scope-PRO Core Question Set)
Baseline
Psychological Distress Score (Scope-PRO Core Question Set)
Baseline
Global Quality of Life Score (Scope-PRO Core Question Set)
Baseline
- +3 more secondary outcomes
Eligibility Criteria
The study is intended for oncology patients before/during/after treatment in DKG-certified oncology centers and organ centers, as well as oncology practices cooperating with a DKG-certified organ or oncology center.
You may qualify if:
- Age ≥ 18 years
- Capacity to give consent
- Cancer patients
- Sufficient understanding of the German language
You may not qualify if:
- Minors
- Lack of capacity to give consent
- Insufficient knowledge of German
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Göttingen, Department of Gastroenterology, gastrointestinal oncology and endocrinology
Göttingen, 37075, Germany
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician
Study Record Dates
First Submitted
November 18, 2025
First Posted
April 1, 2026
Study Start
December 1, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 1, 2026
Record last verified: 2026-03